Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)Anna Candoni, Francesca Bonifazi, Alessandro Rambaldi et al.|Transplantation and Cellular Therapy|2019Cited by 49
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld StudyMichele Malagola, Domenico Russo, Nicola Polverelli et al.|Transplantation Direct|2023Cited by 10
447 | POLATUZUMAB‐CONTAINING REGIMENS AS BRIDGE TO CAR‐T: INSIGHTS FROM THE ITALIAN CAR T‐SIE STUDYGiulia Gabrielli, P. L. Zinzani, Benedetta Casadei et al.|Hematological Oncology|2025Cited by 0
Polatuzumab vedotin–containing regimens as bridge to CART: analysis from the CART-SIE studyGiulia Gabrielli, Pier Luigi Zinzani, Massimo Martino et al.|Blood Advances|2026Cited by 0